Structural correlates of antibodies associated with acute reversal of amyloid beta-related behavioral deficits in a mouse model of Alzheimer disease.
Basi, G.S., Feinberg, H., Oshidari, F., Anderson, J., Barbour, R., Baker, J., Comery, T.A., Diep, L., Gill, D., Johnson-Wood, K., Goel, A., Grantcharova, K., Lee, M., Li, J., Partridge, A., Griswold-Prenner, I., Piot, N., Walker, D., Widom, A., Pangalos, M.N., Seubert, P., Jacobsen, J.S., Schenk, D., Weis, W.I.(2010) J Biol Chem 285: 3417-3427
- PubMed: 19923222 
- DOI: 10.1074/jbc.M109.045187
- Primary Citation of Related Structures:  
3IFL, 3IFN, 3IFO, 3IFP - PubMed Abstract: 
Immunotherapy targeting of amyloid beta (Abeta) peptide in transgenic mouse models of Alzheimer disease (AD) has been widely demonstrated to resolve amyloid deposition as well as associated neuronal, glial, and inflammatory pathologies. These successes have provided the basis for ongoing clinical trials of immunotherapy for treatment of AD in humans ...